tiprankstipranks
Trending News
More News >
H.U.Group Holdings, Inc. (JP:4544)
:4544
Advertisement

HUGroup Holdings (4544) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4544

HUGroup Holdings

(OTC:4544)

Select Model
Select Model
Select Model
Neutral 62 (OpenAI - 4o)
Rating:62Neutral
Price Target:
¥4,184.00
▲(12.20% Upside)
HUGroup Holdings shows a strong recovery in revenue growth, contributing positively to its financial performance score. However, high P/E ratio and overbought technical indicators suggest caution. The stable balance sheet and dividend yield provide some support, but profitability and cash flow management need improvement for a higher score.

HUGroup Holdings (4544) vs. iShares MSCI Japan ETF (EWJ)

HUGroup Holdings Business Overview & Revenue Model

Company DescriptionHUGroup Holdings (4544) is a diversified financial services company based in Japan, primarily engaged in the insurance and asset management sectors. The company offers a range of products and services, including life insurance, non-life insurance, and investment management solutions, catering to both individual and corporate clients. With a focus on innovation and customer-centric solutions, HUGroup Holdings aims to enhance financial security and wealth management for its clients.
How the Company Makes MoneyHUGroup Holdings generates revenue primarily through its insurance premiums from life and non-life insurance policies. The company collects premiums from policyholders in exchange for coverage against various risks, which constitutes a significant portion of its revenue stream. Additionally, HUGroup Holdings earns money through investment income generated from the premiums it collects, as these funds are invested in various financial instruments. The company also benefits from asset management fees charged to clients who utilize its investment management services. Strategic partnerships with financial institutions and distribution networks further bolster its earnings, allowing for a wider reach and customer base, thereby contributing to its overall revenue growth.

HUGroup Holdings Financial Statement Overview

Summary
HUGroup Holdings is navigating through a phase of recovery with improving operating margins and a robust equity base. While revenue growth has been modest, the recovery in EBIT and EBITDA margins suggests operational improvements. The balance sheet remains strong, although rising debt levels warrant attention. Cash flow management appears to be improving, but past volatility suggests the need for cautious cash flow strategies moving forward.
Income Statement
65
Positive
HUGroup Holdings has shown fluctuating revenue trends with a recent annual growth rate of 2.56%. Gross profit margins have been relatively stable, averaging around 27% over the years, but there was a significant dip in net income during 2024. The company has managed to recover its EBIT and EBITDA margins in 2025, indicating some operational recovery.
Balance Sheet
70
Positive
The company's balance sheet reflects strong equity, with a moderate debt-to-equity ratio of 0.63 in 2025. There is a consistent high equity ratio averaging around 48%, indicating a strong capital base. However, the increase in total debt over the years suggests a potential leverage risk.
Cash Flow
60
Neutral
HUGroup Holdings has seen volatility in its free cash flow, with a significant recovery in 2025 after a negative free cash flow in 2024. The operating cash flow to net income ratio is robust, indicating efficient cash generation relative to net income. However, the fluctuations in free cash flow highlight potential cash management challenges.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue244.95B243.03B236.95B260.91B272.94B223.02B
Gross Profit68.59B66.72B63.23B89.92B111.80B76.21B
EBITDA25.18B24.55B13.65B43.08B56.34B33.63B
Net Income1.36B2.76B-7.55B15.68B29.60B17.47B
Balance Sheet
Total Assets271.17B279.58B290.85B297.92B286.59B252.75B
Cash, Cash Equivalents and Short-Term Investments36.05B40.88B39.95B44.41B46.71B42.96B
Total Debt70.31B86.65B81.94B77.16B73.00B80.45B
Total Liabilities139.16B142.28B148.34B147.88B146.41B137.45B
Stockholders Equity131.85B137.29B142.50B150.04B140.18B115.31B
Cash Flow
Free Cash Flow17.11B17.88B-1.01B10.85B20.10B14.40B
Operating Cash Flow20.26B21.96B16.55B32.53B55.23B35.59B
Investing Cash Flow-12.68B-15.96B-16.05B-29.58B-30.86B-28.27B
Financing Cash Flow-5.34B-5.30B-5.78B-5.76B-21.73B-1.57B

HUGroup Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3729.00
Price Trends
50DMA
3635.39
Positive
100DMA
3399.05
Positive
200DMA
3023.96
Positive
Market Momentum
MACD
70.04
Positive
RSI
52.19
Neutral
STOCH
13.75
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4544, the sentiment is Positive. The current price of 3729 is below the 20-day moving average (MA) of 3776.95, above the 50-day MA of 3635.39, and above the 200-day MA of 3023.96, indicating a neutral trend. The MACD of 70.04 indicates Positive momentum. The RSI at 52.19 is Neutral, neither overbought nor oversold. The STOCH value of 13.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4544.

HUGroup Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
¥3.94B7.912.05%2.23%12.02%
€144.33B21.675.29%3.28%5.31%7.90%
¥25.47B13.455.06%1.01%13.91%
¥57.64B12.112.48%6.23%-31.45%
¥75.24B20.102.38%4.36%79.43%
¥214.66B153.810.95%3.35%2.15%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4544
HUGroup Holdings
3,760.00
1,230.18
48.63%
JP:4694
BML
3,655.00
1,029.14
39.19%
JP:4549
Eiken Chemical Co., Ltd.
2,354.00
124.67
5.59%
JP:4671
FALCO HOLDINGS Co., Ltd
2,482.00
232.11
10.32%
JP:4886
ASKA Pharmaceutical Holdings Co., Ltd.
2,094.00
-40.38
-1.89%
JP:9776
Sapporo Clinical Laboratory Center, Inc.
1,122.00
164.38
17.17%

HUGroup Holdings Corporate Events

H.U. Group Completes Treasury Stock Acquisition
Oct 24, 2025

H.U. Group Holdings, Inc. has completed the acquisition of 1,350,400 of its common shares, totaling approximately 4.99 billion yen, through market purchases on the Tokyo Stock Exchange. This acquisition is part of a previously resolved plan by the Board of Directors to repurchase up to 2.5 million shares, aiming to enhance shareholder value and optimize capital structure.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen4184.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports No Treasury Stock Acquisition in September
Oct 1, 2025

H.U. Group Holdings, Inc. announced that it has not acquired any treasury stock during the period from September 1 to September 30, 2025, despite a resolution to acquire up to 2,500,000 shares. The company had planned to repurchase shares as part of a strategy to manage its capital structure, but no shares were acquired during the specified period, potentially impacting its financial strategies and market perception.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3489.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Introduces Stock Grant ESOP Trust to Boost Employee Engagement
Sep 26, 2025

H.U. Group Holdings has introduced a ‘Stock Grant ESOP Trust’ to incentivize managers and employees by granting them company shares, aiming to boost engagement and retention. This plan is part of their strategy to align employee interests with corporate goals, enhancing sustainable value creation and corporate value.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3489.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Revises Earnings Forecast Following Asset Sales
Sep 25, 2025

H.U. Group Holdings has announced the sale of certain non-current assets and shares, resulting in extraordinary income and a revised full-year earnings forecast for the fiscal year ending March 2026. These transactions are part of the company’s strategic plan to optimize capital allocation and improve capital efficiency, which is expected to increase the company’s return on equity.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3489.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Transfers Majority Stake in Care’x to Wakita
Sep 16, 2025

H.U. Group Holdings has decided to transfer 80% of its shares in Care’x Inc. to Wakita & Co., aiming to enhance Care’x’s growth potential by leveraging Wakita’s strategic investments in the nursing care market. This move aligns with H.U. Group’s strategy to improve capital efficiency and focus on investment returns, while Care’x will benefit from Wakita’s expertise and resources to navigate the competitive welfare equipment rental market.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3927.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports No Treasury Stock Acquisitions
Sep 1, 2025

H.U. Group Holdings announced that despite a resolution to acquire up to 2,500,000 of its own shares, no shares were acquired during the specified period from August 1 to August 29, 2025. This decision, initially resolved at a Board of Directors meeting in May 2025, was intended to be executed through market purchases on the Tokyo Stock Exchange, with a total acquisition cost of up to ¥5 billion. The lack of acquisition could impact the company’s stock valuation and shareholder expectations.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3927.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports Q1 2025 Financial Results with Optimistic Outlook
Aug 8, 2025

H.U. Group Holdings reported its consolidated financial results for the three months ending June 30, 2025, showing a 3.2% increase in net sales compared to the previous year. Despite the rise in sales, the company faced a loss attributable to owners of the parent, indicating challenges in profitability. The financial outlook for the fiscal year ending March 31, 2026, remains optimistic with expected growth in net sales and operating profit, suggesting a potential recovery in the company’s financial performance.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen2700.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

H.U. Group Holdings Reports No Treasury Stock Acquisition
Aug 1, 2025

H.U. Group Holdings announced that it did not acquire any treasury stock during the specified period from July 1 to July 31, 2025, despite a prior resolution to purchase up to 2,500,000 shares. This lack of acquisition may impact the company’s stock market strategy and shareholder value, as the intended market purchases were not executed.

The most recent analyst rating on (JP:4544) stock is a Hold with a Yen3000.00 price target. To see the full list of analyst forecasts on HUGroup Holdings stock, see the JP:4544 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 21, 2025